📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

540 Vemurafenib alters glucose utilization in BRAF-driven human melanoma cells (2014)

First Author: Miniotis M

Attributed to: Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0959-8049(14)70666-5

Publication URI: http://dx.doi.org/10.1016/s0959-8049(14)70666-5

Type: Journal Article/Review

Parent Publication: European Journal of Cancer